Method for detecting 1494 C-T and 1555 A-G mutation of maternally inherited deafness mitochondrial genes, and kit thereof

A 1494C-T, mitochondrial gene technology, applied in the field of genetic engineering, can solve the problems of inability to achieve fast, accurate, and low cost, and achieve the effects of avoiding drug-induced deafness, simplifying the experimental process, and being easy to operate

CN101684498AInactive Publication Date: 2010-03-31董大光
1 Cites 5 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2010-03-31
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention relates to a method for detecting 1494 C-T and 1555 A-G mutation of maternally inherited deafness mitochondrial genes. The method comprises the steps of designing improved primers and detecting 1494 C-T and 1555A-G mutation through Touch-down PCR amplification and agarose gel electrophoresis. The method has the advantages of simplicity, low cost, direct reliable detection result andapplicability to the large-scale screening or preventive examination for the 1494 C-T and 1555 A-G mutation of maternally inherited deafness mitochondrial genes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical field:

[0001] The invention relates to the technical field of genetic engineering, in particular to a method for detecting the 1494-position C-T mutation and the 1555-position A-G mutation of the mitochondrial gene of maternally inherited deafness. The present invention also relates to the preparation of a kit for in vitro detection of the 1494 C-T mutation and the 1555 A-G mutation of the mitochondrial gene of maternally inherited deafness according to the method, and the application of the kit in detecting the 1494 C-T mutation and the 1555 A-G mutation . Background technique:

[0002] Aminoglycoside antibiotics (streptomycin, gentamycin, kanamycin, tobramycin and micronomycin, etc.) are widely used clinically because of their broad-spectrum and high-efficiency antibacterial effects and low prices. Controls Gram-negative and positive bacterial infections, but these antibiotics have severe ototoxic effects and can cause irreversible hearing loss in patients. Stu...

Examples

Embodiment 1

[0069] Example 1 Detection of mitochondrial gene 1494C-T mutation and 1555A-G mutation in a family with maternally inherited deafness

[0070] 1. Test samples

[0071] Nine deaf families with maternal inheritance as the transmission feature were selected, with a total of 137 people and 30 subjects. Use the column centrifugal blood genomic DNA extraction kit produced by Shanghai Huashun Bioengineering Co., Ltd. to extract peripheral whole blood DNA from the tested individual as a test sample. The comprehensive information of the 9 families is shown in Table 1. pedigree see Figure 5 with Image 6 . The mode of disease transmission in the remaining families was similar.

[0072] 2. Primer design

[0073] Use Genetool Lite and primer premier 5.0 programs to assist in the design of primers. According to the published mitochondrial gene Cambridge sequence (Cambridge Sequence), the primer design scheme is as follows:

[0074] (1) The 3' ends of the sequence SEQ ID NO: 2 and th...

Embodiment 2

[0102] Detection of 1494C-T and 1555A-G mutations in mitochondrial genes of maternally inherited deafness using in vitro detection kits

[0103] 1. Kit composition:

[0104] 1. Reagents for extracting DNA from blood samples;

[0105] 2. PCR reagents

[0106] 10mM dNTP 0.5ml;

[0107] 10×PCR buffer (containing 15mM Mg 2+ ) 1ml;

[0108] 5U / μl Taq enzyme 2500μl

[0109] 1ml each of the four 10μM primers

[0110] 3. The nucleotide sequences of the four primers are:

[0111] Primer ID NO: 1AAGTGGCTTTAACATATCTG

[0112] Primer ID NO: 2TTGAAGTATACTTGAGCAGA

[0113] Primer ID NO: 3ACGCATTTATATAGAGCAGG

[0114] Primer ID NO: 4TCAATTTCTATCGCCTATAC

[0115] 4. Positive control sample 100μl, negative control sample 100μl

[0116] Wherein: the two positive controls are the PCR amplification products of the 1494C-T and 1555A-G mutant genes of mitochondrial DNA respectively, and the negative sample control is the PCR amplification products of the normal genes.

[0117] 5. Instru...

Embodiment 3

[0137] Detection of 1494C-T and 1555A-G mutations in mitochondrial genes of maternally inherited deafness using in vitro detection kits

[0138] 1. Kit composition:

[0139] 1. Reagents for extracting DNA from blood samples;

[0140] 2. PCR reagents

[0141] 10mM dNTP 0.5ml;

[0142] 10×PCR buffer (containing 15mM Mg 2+ ) 1ml;

[0143] 5U / μl Taq enzyme 2500μl

[0144] 1ml each of the four 10μM primers

[0145] 6. The nucleotide sequences of the four primers are:

[0146] Primer ID NO: 1AAGTGGCTTTAACATATCTG

[0147] Primer ID NO: 5TTGAAGTATACTTGAGCAGG

[0148] Primer ID NO: 6 ACGCATTTATATAGAGCAGA

[0149] Primer ID NO: 4TCAATTTCTATCGCCTATAC

[0150] 7. Positive control sample 100μl, negative control sample 100μl

[0151] Among them: the two positive controls are artificially synthesized products of 1494C-T and 1555A-G mutant genes of mitochondrial DNA, respectively, and the negative sample control is artificially synthesized products of normal genes.

[0152] 8. Ins...